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The aim of this study was to prepare enzymatic hydrolysates from whey protein concentrate with a 
nutritionally adequate peptide profile and the ability to inhibit angiotensin-converting enzyme (ACE) 
activity. The effects of the type of enzyme used (pancreatin or papain), the enzyme:substrate ratio 
(E:S ratio=0.5:100, 1:100, 2:100 and 3:100) and the use of ultrafiltration (UF) were investigated. The 
fractionation of peptides was performed by size-exclusion-HPLC, and the quantification of the components 
of the chromatographic fractions was carried out by a rapid Corrected Fraction Area method. The ACE 
inhibitory activity (ACE-IA) was determined by Reverse Phase-HPLC. All parameters tested affected 
both the peptide profile and the ACE-IA. The best peptide profile was achieved for the hydrolysates 
obtained with papain, whereas pancreatin was more advantageous in terms of ACE-IA. The beneficial 
effect of using a lower E:S ratio on the peptide profile and ACE-IA was observed for both enzymes 
depending on the conditions used to prepare the hydrolysates. The beneficial effect of not using UF on 
the peptide profile was observed in some cases for pancreatin and papain. However, the absence of UF 
yielded greater ACE-IA only when using papain.
Uniterms: Whey proteins. Protein hydrolysates. Peptide profile. Inhibitory activity. Angiotensin-
converting enzyme.
O objetivo deste estudo foi preparar hidrolisados enzimáticos do concentrado proteico do soro de leite 
com perfil peptídico nutricionalmente adequado e com capacidade para inibir a atividade da enzima 
conversora da angiotensina (ECA). Os efeitos do tipo de enzima usado (pancreatina ou papaína), da 
relação enzima:substrato (E:S=0,5:100, 1:100, 2:100 e 3:100) e do uso da ultrafiltração (UF) foram 
investigados. O fracionamento dos peptídeos foi feito por CLAE de exclusão molecular e a quantificação 
dos componentes das frações cromatográficas foi realizada pelo método da Área Corrigida da Fração. A 
atividade inibitória da ECA (AI-ECA) foi determinada por CLAE de fase reversa. Todos os parâmetros 
testados afetaram tanto o perfil peptídico quanto a AI-ECA. O melhor perfil peptídico foi atingido para 
os hidrolisados obtidos com papaína, enquanto a pancreatina foi mais vantajosa em termos da AI-ECA. 
O efeito benéfico do uso de menor relação E:S sobre o perfil peptídico e a AI-ECA foi observado para 
ambas as enzimas dependendo das condições usadas para o preparo dos hidrolisados. O efeito benéfico 
da ausência da UF sobre o perfil peptídico foi observado em alguns casos para pancreatina e papaína. 
No entanto, a ausência da UF produziu maior AI-ECA somente quando a papaína foi usada.
Unitermos: Proteínas do soro de leite. Hidrolisados proteicos. Perfil peptídico. Atividade inibitória. 
Enzima conversora de angiotensina.
INTRODUCTION
Whey is currently a major by-product of the modern 
cheese and casein production industries and represents 
an important source of environmental pollution due to 
its large volume, production rate and high organic mat-
ter content (Román et al., 2009). This dairy stream also 
represents an excellent source of functional proteins and 
peptides, which have helped to transform whey from a 
waste material to a valuable dairy stream for use in the 
agri-food, biotechnology, medical and related markets 
(Smithers, 2008).
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The use of whey in natura is limited due to its perish-
able nature and the excessive dilution of its components. 
However, certain membrane separation technologies can 
be used to partially concentrate the whey, giving rise 
to whey protein concentrate (WPC), which consists of 
35-80% protein (Brans et al., 2004).
Enzymatic hydrolysis of WPC is a well-known 
method for increasing the aggregate value of its proteins 
by modifying their solubility, viscosity and emulsifying 
and foaming properties and, more importantly, for improv-
ing their nutritional properties. WPC hydrolysates are 
considered ideal ingredients in the formulation of human 
milk substitutes due to their high nutritional value, low bit-
terness and low antigenicity (Guadix, Camacho, Guadix, 
2004). The hydrolytic reaction must be strictly controlled 
to produce hydrolysates with the appropriate peptide pro-
files for nutritional purposes. These protein hydrolysates 
may have several applications in specialty foods, such as 
those designed to provide nutritional support to individu-
als with particular physiological or nutritional needs not 
covered by conventional diets (Pacheco, Amaya-Farfan, 
Sgarbieri, 2002).
As the functional and nutritional properties of 
protein hydrolysates are affected by peptides of different 
sizes, it is important to understand the molecular weight 
distribution profile, which is commonly measured using 
Size Exclusion Chromatography. An efficient method 
was previously developed by Silvestre, Hamon and 
Yvon (1994a,b) using this principle, which enabled the 
separation of peptides with molecular masses lower than 
1,000 Da, and this is the method used in the current study. 
This method was used for the characterisation of the 
peptide profiles of hydrolysates obtained from different 
protein sources (Carreira et al., 2004; Lopes et al., 2005, 
2008; Morais et al., 2005; Silva et al., 2007).
Protein hydrolysates are also a source of bioactive 
peptides that are inactive in the intact protein but become 
active after hydrolysis. These peptides have many beneficial 
actions in the organism, such as antihypertensive proper-
ties (Hartmann, Meisel, 2007). Angiotensin-converting 
enzyme (ACE) plays a crucial role in the regulation of blood 
pressure by converting angiotensin I into angiotensin II, a 
potent vasoconstrictor, and by simultaneously inactivat-
ing bradykinin, a vasodilator (Simões Silva, Flynn, 2012). 
Hydrolysates and peptides derived from milk proteins may 
exhibit inhibitory activity (IA) against ACE. Thus, these 
proteins could be introduced into the diet as an alternative, 
non-pharmacological approach to preventing and treating 
arterial hypertension (Costa, Gontijo, Netto, 2007; Jiang et 
al., 2007; Miguel et al., 2007; Otte et al., 2007).
This work focused on the study of the action of pan-
creatin and papain in obtaining WPC hydrolysates with 
peptide profiles that were nutritionally appropriate and 
conferred ACE inhibitory activity. The effects of several 
parameters, such as enzyme type, E:S ratio and the use of 
UF, were evaluated.
MATERIAL AND METHODS
Material
Powdered whey protein concentrate (WPC - Kerrylac 
750) was kindly furnished by Kerry do Brazil Ltd (Três 
Corações, MG, Brazil). Pancreatin (Corolase PP® from 
porcine pancreas, EC 3.4.21.4, activity of 34.7 U mL-1) 
and papain (Corolase L10®, EC 3.4.22.2, activity of 31.6 
U mL-1) were kindly provided by AB Enzymes (Barueri, 
SP, Brazil). In this study, enzyme activity was defined as 
the amount of enzyme required to liberate 1 g of tyrosine 
in one min at 37 ºC. Formic acid was purchased from 
Merck (Whitehouse Station, NJ, USA). The polyvinylidene 
fluoride membranes (0.22 mm for samples and 0.45 mm for 
solvents) and the tangential flow filtration system of 10 
kDa porosity were purchased from Millipore (São Paulo, 
SP, Brazil). The HPLC system used for fractionating the 
protein hydrolysates consisted of one isocratic pump and 
a UV-Vis detector (1200 Series, Agilent, Santa Clara, CA, 
USA) coupled to a computer with ChemStation software 
for LC Systems (Agilent, Santa Clara, CA, USA). A poly(2-
hydroxyethylaspartamide)-silica (PHEA) column (250 x 
9.4 mm, 5 mm and 200 Å pore size) was used for HPLC. 
Angiotensin-converting enzyme (ACE) from rabbit lung, 
0.25 units mg-1 of protein, EC 3.4.15.1, Hippuryl-histidyl-
leucine (HHL) and hippuric acid were purchased from 
Sigma (St. Louis, MO, USA). HPLC-grade trifluoroacetic 
acid was purchased from Vetec (Duque de Caxias, RJ, Bra-
zil). HPLC-grade acetonitrile was acquired from J.T. Backer 
(Phillipsburg, NJ, USA). The reversed-phase high perfor-
mance liquid chromatography (RP-HPLC) system consisted 
of a GraceSmart chromatography column RP-18, 150 x 46 
mm, 5 mm, 120 Å (Grace Davison, Deerfield, IL, USA), a 
quaternary pump and a UV-VIS spectrophotometer (HP 
series 1100, Waldbronn, Germany) coupled to a computer 
with analytical software (HP chemstation, Avondale, USA). 
The water for HPLC was purified by passage through an 
Aries Vaponics water purification system (Rockland, USA). 
All of the solvents used in this study were analytical grade.
Preparation of enzymatic hydrolysates from whey 
protein concentrate
Sixteen hydrolysates were prepared by varying the 
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following parameters: type of enzyme, enzyme:substrate 
ratio (E:S) and the use of UF. The conditions used for pre-
paring these hydrolysates are displayed in Table I. Solutions 
of whey protein concentrate (10% w/v) were prepared with 
distilled water; the concentration of protein in each solu-
tion was 3.42%, and the pH was adjusted to 7.0 with a 3 
M NaOH solution. The solutions were heated in a Vaseline 
bath under constant agitation by a magnetic stirrer (752A 
model, Fisatom, São Paulo, SP, Brazil) at the optimal tem-
perature for each enzyme (50 °C for pancreatin and 55 °C 
for papain), followed by the addition of these enzymes to 
obtain the desired E:S ratio. The total hydrolysis time was 
5 h, and after this time, the enzymes were inactivated by 
heating in a water bath at 75 °C for 15 sec. The samples were 
subsequently lyophilised (Freeze Dry System / Freezone 
4.5, model 77500, Labconco, Kansas City, MO, USA).
Ultrafiltration of protein hydrolysates
Some samples of protein hydrolysates (Table I) were 
submitted to UF and diafiltration using a volume of water 
equivalent to ten times the initial volume. A system of 
tangential flow with a 10 kDa cut-off membrane coupled 
to a peristaltic pump was used. The samples were subse-
quently lyophilised.
Characterisation of peptide profiles from WPC 
hydrolysates
The characterisation of peptide profiles was per-
formed in two stages, which included the fractionation of 
peptides according to size and their subsequent quantifi-
cation. The fractionation of WPC hydrolysates was con-
ducted by size exclusion (SE) HPLC on a PHEA column, 
according to the method previously developed by Silves-
tre, Hamon and Yvon (1994a), using 0.05 M formic acid 
(pH 2.5) as the mobile phase, with isocratic conditions at 
a flow rate of 0.5 mL min-1 for 35 min. The samples were 
dissolved in the mobile phase (0.1%) and filtered through 
a 0.22 mm membrane, and 50 mL of these solutions was 
injected into the column. The mobile phase was filtered 
through a 0.45 mm membrane and degassed by sonication 
in an ultrasound bath (USC1400 model, Unique, Santo 
Amaro, SP, Brazil) for 30 min before use.
The rapid method of Correct Fraction Area (CFA) 
that was previously developed by Silvestre, Hamon and 
Yvon (1994b) was used for quantifying the peptides and 
free amino acids in the SE-HPLC fractions of the WPC hy-
drolysates. Briefly, five whey standard hydrolysates (two 
using trypsin and three using pancreatin) were prepared 
and then fractionated into four fractions by SE-HPLC, as 
described above. The four fractions were collected (Frac-
tion Collector, CF-1 model, Spectrum Chrom, Houston, 
TX, USA) and submitted to amino acid analysis follow-
ing solvent removal (Centrivap, 78100-00D model, Lab-
conco, Kansas City, MO, USA). The calculation of CFA 
was performed using specific formulas after detection at 
three wavelengths (230, 280 and 300 nm) to remove the 
contribution of aromatic amino acids. A standard curve 
was drawn to correlate CFA with the amino acid contents 
of the fractions.
Evaluation in vitro of the ACE-inhibitory activity 
of the protein hydrolysates
Evaluation of the ACE-inhibitory activity of the 
WPC hydrolysates was performed according to the 
method developed by Wu, Aluko and Muir (2002) using 
RP-HPLC. Initially, a volume of 12.5 mL of the substrate 
hippuryl-histidyl-leucine (HHL) (2.17 mM) was mixed 
with 50 mL of hydrolysed WPC (10 mg mL-1), both pre-
pared with a 100 mM borate buffer, pH 8.3, containing 300 
mM NaCl, and the mixture was incubated at 37 °C for 10 
min. A volume of 200 mL of ACE (4 mU), prepared in the 
same buffer, was subjected to a similar treatment. The two 
solutions were subsequently mixed, and after incubation at 
37 °C for 30 min, the reaction was stopped by the addition 
TABLE I - Hydrolytic conditions used in preparing hydrolysates 
from WPC
Hydrolysates Enzyme type E:S Ultrafiltration
H1 Pancreatin 0.5:100 No
H2 Pancreatin 0.5:100 Yes
H3 Pancreatin 1:100 No
H4 Pancreatin 1:100 Yes
H5 Pancreatin 2:100 No
H6 Pancreatin 2:100 Yes
H7 Pancreatin 3:100 No
H8 Pancreatin 3:100 Yes
H9 Papain 0.5:100 No
H10 Papain 0.5:100 Yes
H11 Papain 1:100 No
H12 Papain 1:100 Yes
H13 Papain 2:100 No
H14 Papain 2:100 Yes
H15 Papain 3:100 No
H16 Papain 3:100 Yes
E:S = enzyme:substrate ratio (w/w).
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of 125 mL of HCl (1 M). Next, the mixture was filtered 
through a 0.22 mm membrane for analysis by RP-HPLC.
For this analysis, a GraceSmart RP-18 column was 
used, and the hippuric acid and HHL were detected at 228 
nm. The elution flux was of 0.5 mL min-1 with a two-solvent 
system: (A) 0.05% TFA in water and (B) 0.05% TFA in ace-
tonitrile. The solvent B was used as following: for the first 
10 min, in a gradient from 5 to 60%; during the following 
2 min it was kept at 60% and for an additional 1 min at 5%. 
This procedure was followed by isocratic elution for 4 min 
at the constant flow rate of 0.5 mL min-1, using the solvent A.
The ACE inhibitory activity was expressed in two 
ways: as a percentage of inhibition and as an IC50 value, 
which is defined as the concentration of hydrolysate (mg 
mL-1) necessary to reduce the activity of the enzyme by 
50%.
Evaluation of the effects of certain parameters
The effects of the type of enzyme, E:S ratio and UF 
on the peptide profile and ACE-inhibitory activity of WPC 
hydrolysates were evaluated. Two enzymes (pancreatin 
and papain) were used for preparing these hydrolysates 
with E:S ratios of 0.5:100, 1:100, 2:100 and 3:100. For 
each of these cases, certain samples were submitted to UF, 
and others were not.
Statistical analysis
All experiments and measurements were performed 
in triplicate. A completely randomised factorial design was 
adopted to investigate the presence of significant effects 
among the various treatments (p<0.05). The results were 
analysed using Statistica software (Statsoft, 2000). An 
analysis of variance was performed to evaluate the peptide 
and free amino acid contents of the chromatographic frac-
tions at each condition, as well as the effects of enzyme type, 
E:S ratio and UF. Duncan’s test was applied to evaluate 
differences between the means (Pimentel-Gomes, 2000).
RESULTS AND DISCUSSION
Peptide and amino acid contents 
As illustrated in Figure 1, the hydrolysates were 
resolved in four fractions: F1, from 13.5 to 18.5 min (large 
peptides with more than 7 amino acid residues); F2, from 
18.5 to 22.5 min (medium peptides with 4 to 7 amino acid 
residues); F3, from 22.5 to 23.5 min (di- and tripeptides); 
and F4, from 23.5 to 32.0 min (free amino acids).
The peptide and free amino acid contents of the 
WPC hydrolysates are presented in Table II, where a 
significant variation in the peptide and free amino acid 
contents among the different samples is observed. To 
choose the most appropriate hydrolysates for the develop-
ment of nutritional supplements for clinical use, previous 
studies were considered. According to Frenhani and Burini 
(1999), during the metabolism of proteins, the first stage 
of hydrolysis leads to the formation of oligopeptides that 
contain 2 to 6 amino acid residues and free amino acids. 
Next, these peptides are broken into di- and tripeptides, 
and the proteins are finally absorbed in the form of di- 
 FIGURE 1 - Chromatographic profile of hydrolysate H5 at 230 nm. PHEA column. Mobile Phase: 0.05 M formic acid. F1: large 
peptides (> 7 amino acid residues); F2: medium peptides (4 to 7 amino acid residues); F3: di- and tripeptides; F4: free amino acids; 
Y: tyrosine peak; W: tryptophan peak. Hydrolysate H5: Enzyme = pancreatin; substrate concentration = 10% (w/v); E:S ratio = 
2:100; hydrolysis time = 5 h; Temperature = 50 °C; pH = 7.0.
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TABLE II - Peptide and free amino acid contents of chromatographic fractions of whey protein hydrolysates
Hydrolysates E:S UF F1 F2 F3 F4
Pancreatin
H1 0.5:100 No 65.94b1 21.51fg2 2.31g4 10.24h3
H2 0.5:100 Yes 39.88f1 31.08c2 9.38e4 19.66f3
H3 1:100 No 36.08gh1 31.02c2 14.77c4 18.13f3
H4 1:100 Yes 30.25i2 23.27e3 12.15d4 34.33c1
H5 2:100 No 31.55i2 33.49ab1 16.98a3 17.99f3
H6 2:100 Yes 30.55i1 27.07d2 14.67c3 27.71d2
H7 3:100 No 25.04j3 32.61b1 15.46bc4 26.89d2
H8 3:100 Yes 21.20k3 34.27a1 15.97b4 28.56d2
Papain
H9 0.5:100 No 71.00a1 16.11i2 2.25g4 10.65h3
H10 0.5:100 Yes 57.10d1 20.41gh2 7.48f4 15.01g3
H11 1:100 No 63.44c1 22.77ef2 2.32g4 11.47h3
H12 1:100 Yes 30.37i2 10.43j4 11.98d3 47.23ª1
H13 2:100 No 54.57e1 19.29h3 2.29g4 23.85e2
H14 2:100 Yes 25.73j2 11.15j4 15.29bc3 47.83ª1
H15 3:100 No 36.76g1 19.43h2 7.08f3 36.73b1
H16 3:100 Yes 34.65h2 19.91h3 7.17f4 38.27b1
Values are in % of nmol of the four fractions and represent the means of triplicate experiments. Different numbers represent 
significantly different values (p<0.05) for different fractions of the same hydrolysate. Different letters represent significantly 
different values (p<0.05) for the same fraction of different hydrolysates. E:S: enzyme:substrate ratio. UF: ultrafiltration. F1: large 
peptides (> 7 amino acid residues); F2: medium peptides (4 to 7 amino acid residues); F3: di- and tripeptides; F4: free amino acids.
and tripeptides and free amino acids. According to the 
same authors, the di- and tripeptides are absorbed more 
efficiently than the free amino acids, which, in turn, have 
greater absorption than the tetra- and larger peptides. For 
equivalent quantities of di- and tripeptides and mixtures of 
amino acids, the di- and tripeptides exhibited absorption 
rates that were approximately 10 times faster. Schaafsma 
(2009) also reported the advantage of di- and tripeptides 
over free amino acids with regard to the rate of absorption. 
In this context, the criteria for choosing the most advanta-
geous hydrolysates in the present work were associated 
with the presence of high amounts of di- and tripeptides 
(fraction F3) and of free amino acids (fraction F4), as well 
as a low content of large peptides (fraction F1).
Thus, it can be inferred that, from a nutritional stand-
point, the best peptide profile was achieved for the hydro-
lysate H14, as it displayed one of the greatest contents of 
di- and tripeptides (15.29%) and free amino acids (47.83%), 
as well as the least amount of large peptides (25.73%). The 
peptide profiles of hydrolysates H7 and H8 come just after 
H14, with the only disadvantage concerning their reduced 
free amino acid contents (26.89% and 28.56%, respective-
ly). Hydrolysate H8 demonstrated an advantage over H14 
regarding its smaller amount of large peptides (21.20%).
The effect of enzymatic hydrolysis on the peptide 
profile of WPC hydrolysates was considered in three stud-
ies. In the first study, the action of a subtilisin (protease 
from Bacillus subtilis, Protemax N200, Prozyn, São Paulo, 
Brazil) under different conditions led to a better peptide 
profile than the best results of the present study (H14, H8 
and H7), with regard to the smaller large peptide content 
(12.28%) (Afonso et al., 2008). In the second study, 
several WPC hydrolysates were prepared using the same 
pancreatin that was used in the present study, but the lots 
and hydrolytic conditions of the WPC were different. 
Most of the hydrolysates exhibited appropriate peptide 
profiles from a nutritional standpoint, with low amounts 
of large peptides (12.80%, on average) and high amounts 
of di- and tripeptides (12.11% on average) and free amino 
acids (49.06% on average) (Afonso et al., 2009). A com-
parison with hydrolysate H14 led to the conclusion that 
these peptide profiles were advantageous due to their lower 
amounts of large peptides, but they were poorer due to 
their lower di- and tripeptide contents. In the third study, 
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different enzymes and reaction conditions from those used 
in the current study were used to hydrolyse WPC. The best 
peptide profile was obtained from the action of Aspergillus 
oryzae protease (E:S 1:100, pH 7, 50 °C, 5 h), which was 
better than that of H14 in terms of the amount of di- and 
tripeptides (16.14%), in addition to the lower large peptide 
content (18.76%) (Silva et al., 2009).
ACE-inhibitory activity of WPC hydrolysates
Among the sixteen hydrolysates evaluated (Table 
III), seven demonstrated high ACE-IA (> 80%: H1, H2, 
H3, H5, H6, H7 and H8), and four demonstrated greater 
activity (> 70%: H4, H13, H14 and H16) than the range 
of values reported in the literature (Otte et al., 2007). 
Three hydrolysates (H9, H11 and H15) displayed moder-
ate inhibitory activity (40-60%) and only two samples 
(H10 and H12) demonstrated a low ability to inhibit ACE 
(<20%). It is noteworthy that the greatest ACE-IA results 
were obtained when pancreatin was used at E:S ratios of 
0.5:100 (in the presence or absence of UF) and 3:100 (in 
the presence of UF).
Moreover, no ACE-IA was found for WPC, indicat-
ing that enzymatic treatment, which gives rise to mol-
ecules of small sizes, is required for the manifestation of 
this bioactive property. A similar phenomenon has already 
been reported in the literature for WPC (Mullally, Meisel, 
Fitzgerald, 1997; Guo, Pan, Tanokura, 2009) and other 
intact proteins (Mullally, Meisel, Fitzgerald, 1997; Jiang 
et al., 2007).
The fact that the whey protein hydrolysates pre-
pared in this study had lower ACE inhibitory activity 
(higher IC50) than the synthetic antihypertensive Captopril 
(IC50 = 0.005 mg mL
-1) does not hinder the application of 
whey protein-derived peptides in the treatment/prevention 
of hypertension. In fact, it is expected that milk protein-
derived ACE inhibitory peptides, unlike Captopril, would 
have no undesirable side-effects (Hayes et al., 2007).
Some studies on the ACE-inhibitory activity of en-
zymatic hydrolysates of WPC were found in the literature. 
Mullally, Meisel and Fitzgerald (1997), using five different 
proteases, obtained hydrolysates with ACE-IA values that 
ranged from 60.8% to 88.6%, which are similar to those 
found for several hydrolysates in the present study. Guo, 
Pan and Tanokura (2009) employed only one enzyme to 
hydrolyse WPC (a protease from L. helveticus) and used 
TABLE III - ACE-inhibitory activity of hydrolysates from WPC
Hydrolysates E:S UF Inhibition of ACE (%) IC50
Pancreatin
H1 0.5:100 No 91.88 ± 0.58a 0.097 ± 0.003k
H2 0.5:100 Yes 90.73 ± 0.51ab 0.103 ± 0.003jk
H3 1:100 No 81.14 ± 2.41cd 0.154 ± 0.013h
H4 1:100 Yes 79.28 ± 1.15de 0.164 ± 0.006gh
H5 2:100 No 82.86 ± 0.64c 0.134 ± 0.004i
H6 2:100 Yes 88.35 ± 1.88b 0.116 ± 0.010j
H7 3:100 No 80.74 ± 0.86cd 0.153 ± 0.005h
H8 3:100 Yes 89.96 ± 0.95ab 0.107 ± 0.005jk
Papain
H9 0.5:100 No 44.15 ± 3.21i 0.350 ± 0.017b
H10 0.5:100 Yes 17.92 ± 1.56j 0.483 ± 0.008ª
H11 1:100 No 50.46 ± 4.43h 0.318 ± 0.023c
H12 1:100 Yes 17.29 ± 1.03j 0.495 ± 0.006ª
H13 2:100 No 78.17 ± 1.50de 0.175 ± 0.008fg
H14 2:100 Yes 72.76 ± 2.15f 0.201 ± 0.011e
H15 3:100 No 62.33 ± 2.02g 0.257 ± 0.010d
H16 3:100 Yes 76.86 ± 0.93e 0.182 ± 0.005f
WPC: Whey protein concentrate, ACE: angiotensin-converting enzyme, E:S: enzyme:substrate ratio, UF: ultrafiltration, IC50: 
concentration of hydrolysate (mg mL-1) necessary to reduce the activity of this enzyme by 50%. The results represent the means ± 
standard deviations. Averages indicated by the same letter in the same column do not differ at 5% of probability by Duncan’s test.
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different temperatures, pHs, E:S ratios and reaction times; 
these researchers obtained hydrolysates with ACE-IA 
values that ranged from 15% to 63%, which are similar to 
those of five hydrolysates in this study that demonstrated 
moderate or low ACE-IA. Tavares et al. (2011) used an 
aqueous extracts of Cynara cardunculus for the hydrolysis 
of WPC, and they noted that the IC50 values of the hydro-
lysates ranged from 0.072 to 0.197 mg mL-1, a range that 
covers most of the values observed in the current study.
Effects of certain parameters on the peptide 
profile and ACE inhibitory activity
The effects of enzyme type, E:S ratio and the use of 
UF were evaluated based on three factors. The first factor 
involved the production of an appropriate peptide profile 
from a nutritional point of view; the second involved the 
production of hydrolysates with high ACE-IA and the third 
involved the reduction of costs for scaling up the process 
(use of low E:S ratio and absence of UF).
Effect of type of enzyme
The influence of the type of enzyme on the peptide 
profile of protein hydrolysates can be seen in Table II. To 
keep the other parameters constant, analysis of the data 
had to consider the following comparisons: 1. with UF: 
H2 with H10, H4 with H12, H6 with H14 and H8 with 
H16; 2. without UF: H1 with H9, H3 with H11, H5 with 
H13 and H7 with H15.
The action of papain produced the best peptide 
profile among all of the hydrolysates (H14). In addition, 
using UF, the action of papain was more advantageous 
than pancreatin in terms of the number of cases (four) 
while the pancreatin was more advantageous than papain 
in only two cases. In the absence of UF, this situation was 
reversed, and pancreatin produced beneficial results in a 
greater number of cases (four) than papain (two).
According to the specificities of the enzymes used 
in the current study, some of the results were expected, 
such in the case of the pancreatin which is an enzymatic 
mixture containing both endopeptidases (trypsin and 
chymotrypsin) and exopeptidases (carboxypeptidases A 
and B) that can lead to the cleavage of protein molecules 
at specific points, yielding the release of a greater amount 
of smaller peptides. Along the same reasoning, being an 
endopeptidase, papain is expected to produce higher large 
peptide content than pancreatin.
Few reports were found in the literature that have 
addressed the effect of enzyme type on the peptide profiles 
of WPC hydrolysates. Regarding the results of other au-
thors, Pacheco and Sgarbieri (2005) reported the effect of 
the actions of three enzymes (a different pancreatin from 
that used in the current study and two proteases, one from 
Bacillus sp. and the other from Bacillus licheniformis) 
on the free amino acid content of WPC, evaluated by ion 
exchange chromatography with derivatization by ninhy-
drin. As in the present work, the pancreatin was the most 
beneficial enzyme due to its release of larger amounts of 
free amino acids, which was followed by the protease from 
Bacillus sp. and then from Bacillus licheniformis. 
Silvestre et al. (2011) evaluated the effects of a sub-
tilisin and the same type of pancreatin used in the current 
work, but from a different lot and under different hydro-
lytic conditions (E:S=4:100; reaction time=10 h). A simi-
larity was observed between the peptide profiles obtained 
by these two enzymes. Comparing the best peptide pro-
files obtained using pancreatin in the previous study with 
those of the current work, a nutritional superiority may 
be observed for the former results, due to the lower large 
peptide content (12.80% and 21.20%, respectively) and 
greater amount of free amino acids (49.06% and 28.56%, 
respectively). However, the di- and tripeptide content ob-
tained in the present study was slightly greater than in the 
previous study (15.97% and 12.11%, respectively). The 
superiority of the peptide profile of the previous study may 
be associated with the greater E:S ratio and the reaction 
time used, as the enzyme activity was not determined in 
the previous work.
In another study, seven enzymes were used to hydro-
lyse WPC, of which one corresponded to the pancreatin 
that was employed in the present study; however, it was 
from a different lot (enzyme activity = 4.71 U mL-1), and 
the hydrolysis was performed under different conditions 
than those used here (E:S=1:100; WPC concentration=7%) 
(Silva et al., 2009). The peptide profiles obtained using A. 
oryzae protease and pancreatin were similar but superior to 
the other enzymes from a nutritional standpoint. Compar-
ing the best peptide profiles using pancreatin obtained in 
the previous study with those of the current work, a nutri-
tional similarity can be observed; the former produced a 
greater amount of free amino acids (38.04% and 28.56%, 
respectively), whereas the di- and tripeptide contents of 
the second study were greater (9.12% and 15.97%, re-
spectively). The large peptide contents were very close in 
both studies (21.35% and 21.20% for the first and second 
studies, respectively. These results indicate that for the 
same enzyme the use of greater E:S ratio and substrate 
concentration, as well as higher-activity enzyme favored 
in the current work the production of small peptides but 
reduced the amount of amino acids released during the 
hydrolysis.
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The influence of enzyme type on the ACE-inhibitory 
activity of protein hydrolysates can be observed in Table 
III. To keep the other parameters constant, analysis of the 
data must consider the following comparisons: 1. with UF: 
H2 with H10, H4 with H12, H6 with H14 and H8 with 
H16; 2. without UF: H1 with H9, H3 with H11, H5 with 
H13 and H7 with H15. Pancreatin was more advantageous 
than papain for all cases.
The choice of the enzyme used for protein hydrolysis 
can affect the ACE-inhibitory activity of the hydrolysates 
because the presence of certain amino acids at the C- and 
N-terminal positions influences this property (Costa, 
Gontijo, Netto, 2007; Hernández-Ledesma et al., 2002). 
The most potent inhibitors consist of peptides containing 
either dicarboxylic or branched amino acid residues, such 
as valine and isoleucine, at the N-terminal position. Fur-
thermore, the presence of hydrophobic amino acids, such 
as tryptophan, tyrosine, phenylalanine and proline, at the 
C-terminal portion is necessary (Costa, Gontijo, Netto, 
2007; Tavares et al., 2011).
The statemens above help to explain, at least in 
part, the superior performance of pancreatin; the action of 
chymotrypsin, one of the enzymes found in this enzymatic 
complex, is associated with the breaking of peptide bonds 
at the C-terminal position of aromatic amino acids, releas-
ing peptides with ACE-inhibitory activity. In contrast, 
papain, which demonstrates only endopeptidase activity 
and acts in the cleavage of substrates containing amino 
acid residues of lysine, arginine and valine, produces less 
potent peptides (Beynon, Bond, 2001).
The influence of the type of enzyme on the ACE-
inhibitory activity of protein hydrolysates has been 
previously studied by other researchers, but only one 
study used WPC as a substrate. Mullally, Meisel and 
Fitzgerald (1997) evaluated the effects of five enzymes 
and demonstrated that the most efficient enzymes were 
trypsin (88.6%) and chymotrypsin (87.7%), followed by 
corolase PP (78.2%), which is a pancreatin, PTN 3.0S (a 
commercial enzyme preparation enriched with trypsin; 
60.8%), and finally, elastase (35.5%).
Effects of the enzyme: substrate ratio
The effects of the E:S ratio (0.5:100; 1:100; 2:100 
and 3:100) on the peptide profiles of WPC hydrolysates 
are displayed in Table II. To keep the other parameters con-
stant, analysis of the data must consider the comparisons 
of two groups for each enzyme. For pancreatin, Group 
1 (without UF) included H1 with H3 with H5 and with 
H7, and Group 2 (with UF) included H2 with H4 with H6 
and with H8. For papain, Group 1 included H9 with H11 
with H13 and with H15, and Group 2 included H10 with 
H12 with H14 and with H16. As indicated in this table, 
an advantage of using a lower E:S ratio was observed in 
some cases for pancreatin. For papain, the use of a lower 
E:S ratio was advantageous only after UF.
The beneficial effect of using a lower E:S ratio on 
the peptide profiles of WPC hydrolysates has already been 
demonstrated in two previous studies. Using the same pan-
creatin as the current work but under different hydrolytic 
conditions (E:S = 1:100; WPC concentration = 7%), it was 
possible to obtain lower amounts of the large peptides and 
greater amounts of free amino acids when the E:S ratio de-
creased from 4:100 to 2:100 (Silva et al., 2009). The action 
of a subtilisin in E:S ratios of 1:100, 2:100 and 4:100 also 
previously demonstrated, in some cases, that the use of a 
lower E:S ratio was advantageous as it was decreased from 
4:100 to 2:100 and from 2:100 to 1:100; this decrease led to 
a reduction in the amount of large peptides and an increase 
in the free amino acid content (Afonso et al., 2009).
The influence of the E:S ratio (0.5:100, 1:100, 2:100 
and 3:100) on the ACE-inhibitory activity of enzymatic 
hydrolysates of WPC can be viewed in Table III. To keep 
the other parameters constant, analysis of the data must 
consider the comparisons of two groups for each enzyme. 
For pancreatin, Group 1 (without UF) included H1 with 
H3 with H5 and with H7, and Group 2 (with UF) included 
H2 with H4 with H6 and with H8. For papain, Group 1 in-
cluded H9 with H11 with H13 and with H15, and Group 2 
included H10 with H12 with H14 and with H16.
As displayed in this table, the value of the E:S ratio 
of 0.5:100 produced the greatest ACE-inhibitory activities 
for pancreatin, with no statistical differences between the 
values found with or without UF. For papain, the greatest 
ACE-inhibitory activities were obtained with an E:S ratio 
of 2:100 and 3:100, without and with UF, respectively. 
The use of a lower E:S ratio can be more advantageous 
depending on the conditions used to prepare the protein 
hydrolysates, a finding that may be related to the existence 
of optimal conditions for hydrolysis. Outside of these con-
ditions, ACE-inhibitory peptides may degrade rather than 
form, which would decrease inhibitory activity (Raghavan, 
Kristinsson, 2009).
In the only study of the effect of the E:S ratio on 
the ACE-inhibitory activity of protein hydrolysates, Guo, 
Pan and Tanokura (2009) demonstrated that the action of 
a protease from Lactobacillus helveticus on WPC led to an 
increase in the ACE-IA when the E:S moved from 0.2:100 
to 0.8:100, where it reached its maximum value (63%) and 
subsequently remained unchanged until an E:S of 1.2:100, 
a value that is far inferior to the maximum found in the 
present study.
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Effect of ultrafiltration
The influence of UF on the peptide profile of WPC 
enzymatic hydrolysates is presented in Table II. To keep 
the other parameters constant, analysis of the data must 
consider the following comparisons: for pancreatin, H1 
with H2, H3 with H4, H5 with H6, H7 with H8; and for 
papain, H9 with H10, H11 with H12, H13 with H14 and 
H15 with H16.
As displayed in this table, the beneficial effect of 
not using UF was observed for pancreatin and papain. For 
pancreatin, an advantage was observed in the absence of 
UF regarding the higher di- and tripeptide contents of H3 
and H5 in comparison to H4 and H6, respectively. For 
papain, the only advantage of not using UF was observed 
regarding the lower amount of large peptides when com-
paring H9 to H10. In fact, this result was expected because 
the membrane used here for the UF retains molecules with 
molecular masses greater than 10,000 Da.
No other reports on the effect of UF on the peptide 
profile of WPC hydrolysates were found in the literature. 
In a study previously conducted in our laboratory for whey 
hydrolysates obtained using a pancreatin different from 
that used here, the best peptide profiles were obtained us-
ing UF (Delvivo et al., 2005).
The effect of UF on the ACE-inhibitory activity of 
protein hydrolysates is displayed in Table III. To keep the 
other parameters constant, analysis of the data must consider 
the following comparisons: for pancreatin, H1 with H2, H3 
with H4, H5 with H6, H7 with H8; and for papain, H9 with 
H10, H11 with H12, H13 with H14 and H15 with H16
The absence of UF was not beneficial when pan-
creatin was used, as the absence of UF resulted in protein 
hydrolysates with either lower ACE-IA values than those 
obtained in the presence of UF (H5 with H6 and H7 with 
H8) or with no significant differences between the ACE-IA 
values for both types of treatment (H1 with H2, H3 with 
H4). However, when using papain in the absence of UF, 
it was possible to obtain hydrolysates with greater ACE-
IA than that obtained in the presence of UF in three cases 
(H9 with H10, H11 with H12 and H13 with H14). In only 
one case (H15 with H16) was this situation reversed. Our 
findings indicate that the absence of UF can be advanta-
geous depending on the hydrolytic conditions used. The 
greater ACE-IA values obtained in the absence of UF may 
be explained by two factors. First, according to Raghavan 
and Kristinsson (2009), there is a synergistic action be-
tween all peptides found in a sample of whole hydrolysates 
(not subjected to any process of separation of peptides). 
Second, depending on the conditions employed, the UF 
process may cause the retention of peptides with structures 
(aromatic amino acids or proline at the C-terminal posi-
tion) that favour ACE-inhibitory activity.
Only one study examined the influence of UF on the 
ACE-inhibitory activity of WPC hydrolysates. Mullally, 
Meisel and Fitzgerald (1997) hydrolysed WPC by trypsin 
and subsequently subjected it to UF. The authors demon-
strated that no change in ACE-IA was observed when a 10 
KDa cut-off membrane was used. 
When taken as a whole, the results obtained both 
here and by other authors indicate that although UF is 
considered by some to be a method for enriching protein 
hydrolysates with peptides exhibiting ACE-inhibitory 
activity (Jiang et al., 2007), this finding is not always 
observed, and depending on the conditions employed, 
especially in the preparation of protein hydrolysates, the 
absence of this process can favour ACE-IA, which may 
reduce the costs of scaling up the process.
CONCLUSION
The type of enzyme, E:S ratio and the use of UF af-
fected the peptide profiles and the ACE inhibitory activity 
of the WPC hydrolysates. The best peptide profile was 
obtained using papain with an E:S ratio of 2:100 and UF, 
whereas pancreatin produced the greatest ACE inhibitory 
activity with an E:S ratio of 0.5:100 (in the presence or 
absence of UF) or 3:100 (in the presence of UF).
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